
NeuroMetrix NURO
Quarterly report 2024-Q3
added 05-16-2026
NeuroMetrix Total Shareholders Equity 2011-2026 | NURO
Annual Total Shareholders Equity NeuroMetrix
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14.3 M | 20.1 M | 23.4 M | 23.2 M | 5.25 M | 2.53 M | 6.1 M | 5.02 M | 4.96 M | 12.6 M | 3.39 M | 7.19 M | 8.8 M | 11.1 M | 20.2 M | 35.7 M | 22.8 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 35.7 M | 2.53 M | 13.3 M |
Quarterly Total Shareholders Equity NeuroMetrix
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 16 M | 17.3 M | 18.8 M | 20.1 M | 19.9 M | 21.4 M | 22 M | 23.4 M | 22 M | 23.4 M | 24.2 M | 23.2 M | 24.2 M | 8.84 M | 5.26 M | 5.25 M | 5.37 M | 5.49 M | 2.51 M | 2.53 M | 3.57 M | 4.86 M | 8.19 M | 6.1 M | 8.86 M | 7.72 M | 6.82 M | 5.02 M | 4.52 M | 4.67 M | 7.85 M | 4.96 M | 7.71 M | 11.6 M | 8.85 M | 12.6 M | 8.49 M | 11.6 M | 1.68 M | 3.39 M | 6.2 M | 7.61 M | 6.05 M | 7.19 M | 5.81 M | 6.44 M | 6.9 M | 8.8 M | 10.6 M | 13.1 M | 15.9 M | 11.1 M | 13.1 M | 15.4 M | 11.1 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 24.2 M | 1.68 M | 10.8 M |
Total Shareholders Equity of other stocks in the Medical instruments industry
| Issuer | Total Shareholders Equity | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
243 K | - | - | $ 810 M | ||
|
The Cooper Companies
COO
|
8.24 B | $ 67.34 | 8.58 % | $ 13.4 B | ||
|
Glaukos Corporation
GKOS
|
656 M | $ 125.0 | 2.72 % | $ 7.15 B | ||
|
Intuitive Surgical
ISRG
|
17.8 B | $ 422.06 | 0.77 % | $ 151 B | ||
|
Alcon
ALC
|
18.8 B | $ 66.81 | 0.35 % | $ 40.4 B | ||
|
ICU Medical
ICUI
|
2.12 B | $ 136.61 | 1.25 % | $ 3.37 B | ||
|
iRhythm Technologies
IRTC
|
153 M | $ 108.11 | 0.7 % | $ 3.46 B | ||
|
Repro Med Systems
KRMD
|
17 M | $ 3.93 | -5.07 % | $ 182 M | ||
|
LeMaitre Vascular
LMAT
|
394 M | $ 94.48 | 0.98 % | $ 2.14 B | ||
|
Masimo Corporation
MASI
|
1.05 B | $ 178.82 | -0.04 % | $ 9.53 B | ||
|
Microbot Medical
MBOT
|
77.6 M | $ 1.84 | -6.12 % | $ 84.3 M | ||
|
Ekso Bionics Holdings
EKSO
|
9.03 M | - | - | $ 28.6 M | ||
|
Milestone Scientific
MLSS
|
2.81 M | $ 0.42 | -4.31 % | $ 34.5 M | ||
|
electroCore
ECOR
|
-1.71 M | $ 8.72 | -12.27 % | $ 74 K | ||
|
Envista Holdings Corporation
NVST
|
3.11 B | $ 23.1 | 1.03 % | $ 3.88 B | ||
|
Haemonetics Corporation
HAE
|
796 M | $ 71.28 | 2.05 % | $ 3.36 B | ||
|
STERIS plc
STE
|
7.18 B | $ 212.35 | 0.05 % | $ 20.9 B | ||
|
Isoray
ISR
|
207 M | - | 0.03 % | $ 108 M | ||
|
STAAR Surgical Company
STAA
|
344 M | $ 29.99 | 0.44 % | $ 1.49 B | ||
|
InfuSystem Holdings
INFU
|
57.3 M | $ 9.24 | 1.32 % | $ 191 M | ||
|
Teleflex Incorporated
TFX
|
3.12 B | $ 129.84 | -1.72 % | $ 5.79 B | ||
|
Utah Medical Products
UTMD
|
119 M | $ 67.65 | -0.5 % | $ 219 M | ||
|
Merit Medical Systems
MMSI
|
1.58 B | $ 64.48 | 2.28 % | $ 3.81 B | ||
|
West Pharmaceutical Services
WST
|
3.18 B | $ 314.5 | -0.89 % | $ 22.7 B | ||
|
Pulse Biosciences
PLSE
|
80.7 M | $ 25.33 | -5.98 % | $ 1.71 B | ||
|
DENTSPLY SIRONA
XRAY
|
1.34 B | $ 10.0 | 1.21 % | $ 1.99 B | ||
|
Retractable Technologies
RVP
|
74.4 M | $ 0.69 | 3.96 % | $ 20.7 M | ||
|
Pro-Dex
PDEX
|
36.6 M | $ 65.21 | -2.67 % | $ 214 M | ||
|
Predictive Oncology
POAI
|
47.7 M | - | - | $ 31.1 M | ||
|
BioLife Solutions
BLFS
|
372 M | $ 26.64 | -1.66 % | $ 1.27 B | ||
|
Stereotaxis
STXS
|
13.5 M | $ 1.78 | -5.07 % | $ 162 M | ||
|
Baxter International
BAX
|
6.13 B | $ 19.38 | 0.16 % | $ 9.94 B | ||
|
ResMed
RMD
|
3.36 B | $ 196.04 | 0.89 % | $ 28.6 B | ||
|
AtriCure
ATRC
|
492 M | $ 27.1 | -0.62 % | $ 1.29 B | ||
|
Harvard Bioscience
HBIO
|
13.7 M | $ 6.2 | -4.4 % | $ 275 M | ||
|
AngioDynamics
ANGO
|
183 M | $ 11.94 | -0.75 % | $ 488 M | ||
|
Becton, Dickinson and Company
BDX
|
25.4 B | $ 151.16 | 1.12 % | $ 43.5 B | ||
|
Nephros
NEPH
|
10.2 M | $ 3.42 | -4.74 % | $ 36.3 M | ||
|
OraSure Technologies
OSUR
|
341 M | $ 4.04 | -3.12 % | $ 297 M | ||
|
Repligen Corporation
RGEN
|
2.11 B | $ 122.31 | -3.35 % | $ 6.88 M |